{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:27:05Z","timestamp":1791977225900,"version":"4.4.0"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["MMA17\/01"],"award-info":[{"award-number":["MMA17\/01"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["PR194"],"award-info":[{"award-number":["PR194"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS-PI17\/00021"],"award-info":[{"award-number":["FIS-PI17\/00021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS-PI17\/00166"],"award-info":[{"award-number":["FIS-PI17\/00166"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010067","name":"Gobierno de Arag\u00f3n","doi-asserted-by":"publisher","award":["LMP135_18"],"award-info":[{"award-number":["LMP135_18"]}],"id":[{"id":"10.13039\/501100010067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.redox.2021.101871","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T11:25:41Z","timestamp":1611314741000},"page":"101871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Down syndrome is an oxidative phosphorylation disorder"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8585-6371","authenticated-orcid":false,"given":"M. Pilar","family":"Bayona-Bafaluy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Garrido-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldris","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Jim\u00e9nez-Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mart\u00ednez-Cu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ruiz-Pesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2021.101871_bib1","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/dmcn.14260","article-title":"New approaches to studying early brain development in Down syndrome","volume":"61","author":"Baburamani","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.redox.2021.101871_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.redox.2021.101871_bib3","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2021.101871_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/pd.4995","article-title":"Fetal therapy for Down syndrome: an ethical exploration","volume":"37","author":"de Wert","year":"2017","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.redox.2021.101871_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","article-title":"Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome","volume":"18","author":"Guidi","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.redox.2021.101871_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/emmm.201302848","article-title":"Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21","volume":"6","author":"Hibaoui","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.redox.2021.101871_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2017.07.026","article-title":"Neurogenesis impairment: an early developmental defect in Down syndrome","volume":"114","author":"Stagni","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101871_bib8","series-title":"Prog. Brain Res.","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/bs.pbr.2019.11.001","article-title":"Plasticity as a therapeutic target for improving cognition and behavior in Down syndrome","author":"Mart\u00ednez Cu\u00e9","year":"2020"},{"key":"10.1016\/j.redox.2021.101871_bib9","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1523\/JNEUROSCI.0026-12.2012","article-title":"Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing","volume":"32","author":"Hall","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20170108","article-title":"Natural history of mitochondrial disorders: a systematic review","volume":"62","author":"Keshavan","year":"2018","journal-title":"Essays Biochem."},{"key":"10.1016\/j.redox.2021.101871_bib11","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1242\/dev.121939","article-title":"Brain oxygen tension controls the expansion of outer subventricular zone-like basal progenitors in the developing mouse brain","volume":"142","author":"Wagenfuhr","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.redox.2021.101871_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1152\/physrev.00041.2017","article-title":"Defining physiological normoxia for improved translation of cell physiology to animal models and humans","volume":"99","author":"Keeley","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.redox.2021.101871_bib13","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1093\/hmg\/ddx217","article-title":"Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis","volume":"26","author":"Khacho","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41583-018-0091-3","article-title":"Mitochondria as central regulators of neural stem cell fate and cognitive function","volume":"20","author":"Khacho","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib15","doi-asserted-by":"crossref","DOI":"10.1089\/scd.2015.0076","article-title":"Differentiation of human neural stem cells into motor neurons stimulates mitochondrial biogenesis and decreases glycolytic flux","volume":"24","author":"O'Brien","year":"2015","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.redox.2021.101871_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ceb.2017.12.004","article-title":"Mitochondrial metabolism in early neural fate and its relevance for neuronal disease modeling","volume":"49","author":"Lorenz","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.redox.2021.101871_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2184.2009.00612.x","article-title":"Trans mitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation","volume":"42","author":"Kirby","year":"2009","journal-title":"Cell Prolif"},{"key":"10.1016\/j.redox.2021.101871_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/stem.2292","article-title":"Concise review: heteroplasmic mitochondrial DNA mutations and mitochondrial diseases: toward iPSC-based disease modeling, drug discovery, and regenerative therapeutics","volume":"34","author":"Hatakeyama","year":"2016","journal-title":"Stem Cell."},{"key":"10.1016\/j.redox.2021.101871_bib19","doi-asserted-by":"crossref","first-page":"e2551","DOI":"10.1038\/cddis.2016.484","article-title":"Mitochondrial respiratory dysfunction disturbs neuronal and cardiac lineage commitment of human iPSCs","volume":"8","author":"Yokota","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2021.101871_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111407","article-title":"Uridine prevents negative effects of OXPHOS xenobiotics on dopaminergic neuronal differentiation","volume":"8","author":"Iglesias","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.redox.2021.101871_bib21","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.18632\/aging.102328","article-title":"Brain pyrimidine nucleotide synthesis and Alzheimer disease","volume":"11","author":"Pesini","year":"2019","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.redox.2021.101871_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/584071","article-title":"Mouse models of down syndrome as a tool to unravel the causes of mental disabilities","author":"Rueda","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.redox.2021.101871_bib23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in Down syndrome research: impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.redox.2021.101871_bib24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ajhg.2018.10.009","article-title":"Human models are needed for studying human neurodevelopmental disorders","volume":"103","author":"Zhao","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib25","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/hmg\/ddl211","article-title":"Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome","volume":"15","author":"Shukkur","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005062","article-title":"Opposite phenotypes of muscle strength and locomotor function in mouse models of partial trisomy and monosomy 21 for the proximal Hspa13-App region","volume":"11","author":"Brault","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.redox.2021.101871_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2007.10.045","article-title":"Mitochondrial dysfunction in mouse trisomy 16 brain","volume":"1188","author":"Bambrick","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2021.101871_bib28","doi-asserted-by":"crossref","first-page":"R1251","DOI":"10.1152\/ajpregu.00312.2012","article-title":"Functional and biochemical characterization of soleus muscle in Down syndrome mice: insight into the muscle dysfunction seen in the human condition","volume":"303","author":"Cowley","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.redox.2021.101871_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1515\/rns.2011.037","article-title":"Is it possible to improve neurodevelopmental abnormalities in Down syndrome?","volume":"22","author":"Bartesaghi","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbadis.2016.03.003","article-title":"The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model","volume":"1862","author":"Valenti","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2021.101871_bib31","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1016\/j.bbadis.2017.09.014","article-title":"Inhibition of Drp1-mediated mitochondrial fission improves mitochondrial dynamics and bioenergetics stimulating neurogenesis in hippocampal progenitor cells from a Down syndrome mouse model","volume":"1863","author":"Valenti","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.redox.2021.101871_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molmed.2019.10.001","article-title":"Challenges and opportunities for translation of therapies to improve cognition in down syndrome","volume":"26","author":"Lee","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.redox.2021.101871_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/stem.1968","article-title":"Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration","volume":"33","author":"Murray","year":"2015","journal-title":"Stem Cell."},{"key":"10.1016\/j.redox.2021.101871_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/15513815.2010.505626","article-title":"T lymphocytes apoptosis and mitochondrial membrane potential in Down's syndrome","volume":"30","author":"Abu Faddan","year":"2011","journal-title":"Fetal Pediatr. Pathol."},{"key":"10.1016\/j.redox.2021.101871_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-160278","article-title":"Metabolic and growth rate alterations in lymphoblastic cell lines discriminate between down syndrome and alzheimer's disease","volume":"55","author":"Coskun","year":"2017","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.redox.2021.101871_bib36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0896-6273(02)00604-9","article-title":"Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome","volume":"33","author":"Busciglio","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.redox.2021.101871_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/BJ20101908","article-title":"Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP\/PKA signalling pathway","volume":"435","author":"Valenti","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2021.101871_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","article-title":"Adaptive downregulation of mitochondrial function in down syndrome","volume":"17","author":"Helguera","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2021.101871_bib39","first-page":"1056","article-title":"Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells","volume":"26","author":"Izzo","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"AUTACs: cargo-specific degraders using selective autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol. Cell."},{"key":"10.1016\/j.redox.2021.101871_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1042\/BJ20100581","article-title":"Impairment of F1F0-ATPase, adenine nucleotide translocator and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy","volume":"431","author":"Valenti","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2021.101871_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2431-12-193","article-title":"Lymphocyte respiration in children with Trisomy 21","volume":"12","author":"Aburawi","year":"2012","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.redox.2021.101871_bib43","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/hmg\/dds529","article-title":"Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects","volume":"22","author":"Piccoli","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbadis.2012.12.011","article-title":"Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome","volume":"1832","author":"Valenti","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2021.101871_bib45","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1911895116","article-title":"Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome","volume":"116","author":"Panagaki","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2021.101871_bib46","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1007\/BF00746056","article-title":"Gingival fibroblasts \u201cin vitro\u201d and Down's Syndrome","volume":"11","author":"Solmi","year":"1993","journal-title":"Cytotechnology"},{"key":"10.1016\/j.redox.2021.101871_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02260938","article-title":"Mitochondrial enzyme deficiencies in Down's syndrome","volume":"8","author":"Prince","year":"1994","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.redox.2021.101871_bib48","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/PL00000661","article-title":"Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome","volume":"57","author":"Kim","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.redox.2021.101871_bib49","article-title":"Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains","volume":"Suppl","author":"Kim","year":"2001","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.redox.2021.101871_bib50","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/S0024-3205(01)01074-8","article-title":"The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease","volume":"68","author":"Kim","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2021.101871_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01422-6","article-title":"Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2021.101871_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/biof.5520320119","article-title":"Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects","volume":"32","author":"Tiano","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.redox.2021.101871_bib53","doi-asserted-by":"crossref","unstructured":"M.E. Zaki, H.T. El-Bassyouni, A.M.S. Tosson, E. Youness, J. Hussein, Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects., J. Pediatr. 93 (n.d.) 100\u2013104. https:\/\/doi.org\/10.1016\/j.jped.2016.04.012.","DOI":"10.1016\/j.jped.2016.04.012"},{"key":"10.1016\/j.redox.2021.101871_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biocel.2017.09.017","article-title":"Dysfunctions of mitochondria in close association with strong perturbation of long noncoding RNAs expression in down syndrome","volume":"92","author":"Qiu","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.redox.2021.101871_bib55","first-page":"211","article-title":"Differential display reveals deteriorated mRNA levels of NADH3 (complex I) in cerebellum of patients with Down syndrome","volume":"57","author":"Krapfenbauer","year":"1999","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.redox.2021.101871_bib56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13577-018-0205-2","article-title":"Mitochondrial mRNA expression in fibroblasts of Down syndrome subjects","volume":"31","author":"Salemi","year":"2018","journal-title":"Hum. Cell"},{"key":"10.1016\/j.redox.2021.101871_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1016-8478(23)13725-3","article-title":"Expression of the mitochondrial ATPase6 gene and Tfam in Down syndrome","volume":"15","author":"Lee","year":"2003","journal-title":"Mol. Cell."},{"key":"10.1016\/j.redox.2021.101871_bib58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2164-8-268","article-title":"Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy","volume":"8","author":"Conti","year":"2007","journal-title":"BMC Genom."},{"key":"10.1016\/j.redox.2021.101871_bib59","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/nn1564","article-title":"Drosophila melanogaster homolog of Down syndrome critical region 1 is critical for mitochondrial function","volume":"8","author":"Chang","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"Suppl 2","key":"10.1016\/j.redox.2021.101871_bib60","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.3233\/JAD-2010-100351","article-title":"Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia","volume":"20","author":"Coskun","year":"2010","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.redox.2021.101871_bib61","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1007\/s12035-019-1585-3","article-title":"Transcriptome and proteome profiling of neural induced pluripotent stem cells from individuals with down syndrome disclose dynamic dysregulations of key pathways and cellular functions","volume":"56","author":"Sobol","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2021.101871_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084031","article-title":"Defective mitochondrial function in vivo in skeletal muscle in adults with Down's syndrome: a 31P-MRS study","volume":"8","author":"Phillips","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.redox.2021.101871_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s10020-020-00225-8","article-title":"Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome","volume":"26","author":"Pecze","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.redox.2021.101871_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/humu.24107","article-title":"Specifications of the ACMG\/AMP standards and guidelines for mitochondrial DNA variant interpretation","author":"McCormick","year":"2020","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.redox.2021.101871_bib65","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1542\/peds.2007-0391","article-title":"Mitochondrial disease: a practical approach for primary care physicians","volume":"120","author":"Haas","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.redox.2021.101871_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197513","article-title":"Mitochondrial disease patient motivations and barriers to participate in clinical trials","volume":"13","author":"Zolkipli-Cunningham","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.redox.2021.101871_bib67","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tins.2020.03.005","article-title":"Prenatal origins of ASD: the when, what, and how of ASD development","volume":"43","author":"Courchesne","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib68","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2010.1706","article-title":"Mitochondrial dysfunction in autism","volume":"304","author":"Giulivi","year":"2010","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.redox.2021.101871_bib69","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.redox.2021.101871_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.redox.2021.101871_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194581","article-title":"Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21","volume":"13","author":"Gonzales","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.redox.2021.101871_bib72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/stem.1297","article-title":"Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology","volume":"31","author":"Briggs","year":"2013","journal-title":"Stem Cell."},{"key":"10.1016\/j.redox.2021.101871_bib73","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.yexcr.2012.09.017","article-title":"Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells","volume":"319","author":"Lu","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.redox.2021.101871_bib74","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/hmg\/ddaa003","article-title":"Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics","volume":"29","author":"Ponroy Bally","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib75","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.2949367","article-title":"Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus","volume":"235","author":"Tanzi","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.redox.2021.101871_bib76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0888-7543(88)90143-7","article-title":"Genetic linkage map of human chromosome 21","volume":"3","author":"Tanzi","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.redox.2021.101871_bib77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1096\/fj.13-232686","article-title":"Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome","volume":"28","author":"Sosa","year":"2014","journal-title":"Faseb. J."},{"key":"10.1016\/j.redox.2021.101871_bib78","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/15592294.2016.1192736","article-title":"Epigenetic dysregulation in the developing Down syndrome cortex","volume":"11","author":"El Hajj","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/j.redox.2021.101871_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/srep32353","article-title":"An integrated human\/murine transcriptome and pathway approach to identify prenatal treatments for down syndrome","volume":"6","author":"Guedj","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2021.101871_bib80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm0196-93","article-title":"Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome","volume":"2","author":"Teller","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2021.101871_bib81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/nbdi.2000.0357","article-title":"Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain","volume":"8","author":"Russo","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2021.101871_bib82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainresbull.2016.08.009","article-title":"Amyloid precursor protein processing and bioenergetics","volume":"133","author":"Wilkins","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.redox.2021.101871_bib83","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1111\/bph.14554","article-title":"Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease","volume":"176","author":"Lopez Sanchez","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2021.101871_bib84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-291X(85)91641-9","article-title":"Cystathionine beta synthase: gene dosage effect in trisomy 21","volume":"128","author":"Chadefaux","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2021.101871_bib85","first-page":"1393","article-title":"Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin","volume":"94","author":"Taub","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.redox.2021.101871_bib86","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2002-07-2337","article-title":"Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines","volume":"101","author":"Ge","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.redox.2021.101871_bib87","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.bbrc.2005.10.118","article-title":"Cystathionine beta-synthase is enriched in the brains of Down's patients","volume":"338","author":"Ichinohe","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2021.101871_bib88","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ygeno.2007.08.005","article-title":"Gene expression profiling in the adult Down syndrome brain","volume":"90","author":"Lockstone","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.redox.2021.101871_bib89","unstructured":"E. Abdel-Salam, M. Aboul-Enein, A. Kotb, M. Elseify, A. Abul-Hassan, S. Ishaac, Hematologic changes in Down's syndrome during infantile and early childhood period., Gaz. Egypt Paediatr. Assoc. 24 (n.d.) 209\u201316. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/145981."},{"key":"10.1016\/j.redox.2021.101871_bib90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/NPM-15814092","article-title":"Expression of cystathionine beta-synthase and histopathological observations in placentas of patients with Down syndrome","volume":"8","author":"Pinilla","year":"2015","journal-title":"J. Neonatal Perinat. Med."},{"key":"10.1016\/j.redox.2021.101871_bib91","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2016.01.042","article-title":"Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination","volume":"89","author":"Olmos-Serrano","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.redox.2021.101871_bib92","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/febs.15214","article-title":"The re-emerging pathophysiological role of the cystathionine-\u03b2-synthase - hydrogen sulfide system in Down syndrome","volume":"287","author":"Szabo","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2021.101871_bib93","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/2201235a0","article-title":"Erythrocyte ATP: D-fructose-6-phosphate 1-phosphotransferase (phosphofructokinase) activity in children with norma\u0142G trisomic mosaic Down's syndrome and in normal and Down's syndrome controls","volume":"220","author":"Benson","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.101871_bib94","first-page":"184","article-title":"Red cell enzymes in trisomy 21","volume":"22","author":"Pantelakis","year":"1970","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib95","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00283052","article-title":"Phosphofructokinase activity in fibroblasts aneuploid for chromosome 21","volume":"76","author":"Anner\u00e9n","year":"1987","journal-title":"Hum. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib96","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12264-016-0032-y","article-title":"Phosphofructokinase-1 negatively regulates neurogenesis from neural stem cells","volume":"32","author":"Zhang","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.redox.2021.101871_bib97","article-title":"Chemical reversal of abnormalities in cells carrying mitochondrial DNA mutations","author":"Kobayashi","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2021.101871_bib98","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12035-012-8284-7","article-title":"BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from Down syndrome patients","volume":"46","author":"Tlili","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2021.101871_bib99","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1755-8794-6-24","article-title":"Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome","volume":"6","author":"Granese","year":"2013","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.redox.2021.101871_bib100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2006.11.026","article-title":"Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome","volume":"413","author":"Dowjat","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2021.101871_bib101","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome","volume":"22","author":"Liu","year":"2008","journal-title":"Faseb. J."},{"key":"10.1016\/j.redox.2021.101871_bib102","doi-asserted-by":"crossref","first-page":"28660","DOI":"10.1074\/jbc.M802645200","article-title":"Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome","volume":"283","author":"Shi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101871_bib103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/NEN.0b013e318202bfa1","article-title":"Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome","volume":"70","author":"Wegiel","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.redox.2021.101871_bib104","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/geno.1999.5775","article-title":"Human minibrain homologue (MNBH\/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome","volume":"57","author":"Guimera","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.redox.2021.101871_bib105","doi-asserted-by":"crossref","first-page":"13074","DOI":"10.1073\/pnas.0601915103","article-title":"A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells","volume":"103","author":"Kim","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2021.101871_bib106","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature04678","article-title":"NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21","volume":"441","author":"Arron","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.101871_bib107","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1073\/pnas.1232352100","article-title":"An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle","volume":"100","author":"Handschin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2021.101871_bib108","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cvr\/cvn098","article-title":"Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha","volume":"79","author":"Ventura-Clapier","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2021.101871_bib109","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000112058","article-title":"Specific transcriptional changes in human fetuses with autosomal trisomies","volume":"119","author":"Altug-Teber","year":"2007","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.redox.2021.101871_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074184","article-title":"Expression signature as a biomarker for prenatal diagnosis of trisomy 21","volume":"8","author":"Volk","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.redox.2021.101871_bib111","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbadis.2013.10.014","article-title":"Decreased cell proliferation and higher oxidative stress in fibroblasts from Down Syndrome fetuses. Preliminary study","volume":"1842","author":"Gimeno","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2021.101871_bib112","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nature08062","article-title":"Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1","volume":"459","author":"Baek","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.101871_bib113","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/hmg\/9.11.1681","article-title":"DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways","volume":"9","author":"Fuentes","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib114","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3233\/JAD-160945","article-title":"Neurons derived from induced pluripotent stem cells of patients with down syndrome reproduce early stages of alzheimer's disease type pathology in vitro","volume":"56","author":"Dashinimaev","year":"2017","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.redox.2021.101871_bib115","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1074\/jbc.M111.305342","article-title":"Chronic expression of RCAN1-1L protein induces mitochondrial autophagy and metabolic shift from oxidative phosphorylation to glycolysis in neuronal cells","volume":"287","author":"Ermak","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101871_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006033","article-title":"A syntenic cross species aneuploidy genetic screen links RCAN1 expression to \u03b2-cell mitochondrial dysfunction in type 2 diabetes","volume":"12","author":"Peiris","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.redox.2021.101871_bib117","doi-asserted-by":"crossref","first-page":"785","DOI":"10.14348\/molcells.2014.0103","article-title":"Overexpression of Rcan1-1L inhibits hypoxia-induced cell apoptosis through induction of mitophagy","volume":"37","author":"Sun","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.redox.2021.101871_bib118","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FJC.0000000000000121","article-title":"Regulator of calcineurin 1-1L protects cardiomyocytes against hypoxia-induced apoptosis via mitophagy","volume":"64","author":"Yan","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.redox.2021.101871_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201600530","article-title":"Lycopene inhibits regulator of calcineurin 1-mediated apoptosis by reducing oxidative stress and down-regulating Nucling in neuronal cells","volume":"61","author":"Lim","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.redox.2021.101871_bib120","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1093\/hmg\/ddu157","article-title":"NRIP1\/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome","volume":"23","author":"Izzo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib121","doi-asserted-by":"crossref","first-page":"112777","DOI":"10.1016\/j.bbr.2020.112777","article-title":"Cognitive impairments in adult mice with RIP140 overexpression in neural stem cells","volume":"393","author":"Wang","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.redox.2021.101871_bib122","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1073\/pnas.0401013101","article-title":"Nuclear receptor corepressor RIP140 regulates fat accumulation","volume":"101","author":"Leonardsson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2021.101871_bib123","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1172\/JCI26040","article-title":"Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes","volume":"116","author":"Powelka","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2021.101871_bib124","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1164\/rccm.200701-161OC","article-title":"Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis","volume":"176","author":"Haden","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.redox.2021.101871_bib125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1194\/jlr.D600033-JLR200","article-title":"RNAi-based gene silencing in primary mouse and human adipose tissues","volume":"48","author":"Puri","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.redox.2021.101871_bib126","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2007.08.004","article-title":"The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle","volume":"6","author":"Seth","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2021.101871_bib127","doi-asserted-by":"crossref","first-page":"E1400","DOI":"10.1152\/ajpendo.90913.2008","article-title":"Muscle-specific differences in the response of mitochondrial proteins to beta-GPA feeding: an evaluation of potential mechanisms","volume":"296","author":"Williams","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.redox.2021.101871_bib128","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvp418","article-title":"Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function","volume":"86","author":"Fritah","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2021.101871_bib129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2012.03.023","article-title":"Roles of transcriptional corepressor RIP140 and coactivator PGC-1\u03b1 in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes","volume":"362","author":"Chen","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.redox.2021.101871_bib130","doi-asserted-by":"crossref","first-page":"R373","DOI":"10.1152\/ajpregu.00183.2011","article-title":"Clenbuterol, a \u03b22-adrenergic agonist, reciprocally alters PGC-1 alpha and RIP140 and reduces fatty acid and pyruvate oxidation in rat skeletal muscle","volume":"302","author":"Hoshino","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.redox.2021.101871_bib131","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1249\/MSS.0b013e31828fc65f","article-title":"Effects of concurrent training on oxidative capacity in rat gastrocnemius muscle","volume":"45","author":"Furrer","year":"2013","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.redox.2021.101871_bib132","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2014.05.005","article-title":"The p65 subunit of NF-\u03baB involves in RIP140-mediated inflammatory and metabolic dysregulation in cardiomyocytes","volume":"554","author":"Zhang","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2021.101871_bib133","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1139\/apnm-2015-0192","article-title":"Changes in nuclear receptor corepressor RIP140 do not influence mitochondrial content in the cortex","volume":"40","author":"Herbst","year":"2015","journal-title":"Appl. Physiol. Nutr. Metabol."},{"key":"10.1016\/j.redox.2021.101871_bib134","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201500870","article-title":"Combined high-fat-resveratrol diet and RIP140 knockout mice reveal a novel relationship between elevated bone mitochondrial content and compromised bone microarchitecture, bone mineral mass, and bone strength in the tibia","volume":"60","author":"Miotto","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.redox.2021.101871_bib135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trsl.2016.08.005","article-title":"Receptor-interacting protein 140 overexpression impairs cardiac mitochondrial function and accelerates the transition to heart failure in chronically infarcted rats","volume":"180","author":"Chen","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.redox.2021.101871_bib136","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/apha.12800","article-title":"Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes","volume":"220","author":"You","year":"2017","journal-title":"Acta Physiol."},{"key":"10.1016\/j.redox.2021.101871_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56817-w","article-title":"Lactobacillus amylovorus KU4 ameliorates diet-induced obesity in mice by promoting adipose browning through PPAR\u03b3 signaling","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2021.101871_bib138","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1242\/jcs.072272","article-title":"A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells","volume":"124","author":"Birket","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.redox.2021.101871_bib139","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/nar\/gkg396","article-title":"Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance","volume":"31","author":"S\u00e1nchez-Font","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2021.101871_bib140","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1093\/nar\/gkq019","article-title":"Down syndrome fibroblasts and mouse Prep1-overexpressing cells display increased sensitivity to genotoxic stress","volume":"38","author":"Micali","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2021.101871_bib141","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/MCB.01232-13","article-title":"Pknox1\/Prep1 regulates mitochondrial oxidative phosphorylation components in skeletal muscle","volume":"34","author":"Kanzleiter","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2021.101871_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144461","article-title":"Gene expression profiling of amniotic fluid mesenchymal stem cells of monozygotic twins discordant for trisomy 21","volume":"738","author":"You","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.redox.2021.101871_bib143","first-page":"193","article-title":"Overexpression of transcription factor BACH1 in fetal Down syndrome brain","volume":"Suppl","author":"Ferrando-Miguel","year":"2003","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.redox.2021.101871_bib144","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1005-x","article-title":"Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism","volume":"568","author":"Lee","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.101871_bib145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.redox.2021.101871_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093134","article-title":"Targeting mitochondrial network architecture in down syndrome and aging","volume":"21","author":"Mollo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2021.101871_bib147","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GCO.0000000000000056","article-title":"Prenatal treatment of Down syndrome: a reality?","volume":"26","author":"Guedj","year":"2014","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.redox.2021.101871_bib148","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnbeh.2015.00265","article-title":"Timing of therapies for Down syndrome: the sooner, the better","volume":"9","author":"Stagni","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib149","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroscience.2020.02.035","article-title":"Activation of PGC-1\u03b1 and mitochondrial biogenesis protects against prenatal hypoxic-ischemic brain injury","volume":"432","author":"Jia","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.redox.2021.101871_bib150","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neubiorev.2016.10.023","article-title":"Plant polyphenols as natural drugs for the management of Down syndrome and related disorders","volume":"71","author":"Vacca","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.redox.2021.101871_bib151","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.08.014","article-title":"Mitochondria as pharmacological targets in Down syndrome","volume":"114","author":"Valenti","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101871_bib152","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neubiorev.2019.01.001","article-title":"Down syndrome: neurobiological alterations and therapeutic targets","volume":"98","author":"Vacca","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.redox.2021.101871_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050697","article-title":"Cystathionine-\u03b2-Synthase: molecular regulation and pharmacological inhibition","volume":"10","author":"Zuhra","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.redox.2021.101871_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8100187","article-title":"DYRK1A protein, A promising therapeutic target to improve cognitive deficits in down syndrome","volume":"8","author":"Feki","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.redox.2021.101871_bib155","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib156","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4137\/NMI.S10233","article-title":"Effects of caffeine on metabolism and mitochondria biogenesis in rhabdomyosarcoma cells compared with 2,4-dinitrophenol","volume":"5","author":"Vaughan","year":"2012","journal-title":"Nutr. Metab. Insights"},{"key":"10.1016\/j.redox.2021.101871_bib157","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4155\/fmc-2017-0204","article-title":"The critical role of epigallocatechin gallate in regulating mitochondrial metabolism","volume":"10","author":"Shi","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.redox.2021.101871_bib158","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.drudis.2018.01.031","article-title":"Increasing mtDNA levels as therapy for mitochondrial optic neuropathies","volume":"23","author":"Ruiz-Pesini","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.redox.2021.101871_bib159","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","article-title":"DYRK1A and cognition: a lifelong relationship","volume":"194","author":"Arbones","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.redox.2021.101871_bib160","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1007\/s12035-016-9924-0","article-title":"Delayed treatment with green tea polyphenol EGCG promotes neurogenesis after ischemic stroke in adult mice","volume":"54","author":"Zhang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2021.101871_bib161","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroscience.2016.07.031","article-title":"Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome","volume":"333","author":"Stagni","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.redox.2021.101871_bib162","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1038\/s41598-019-40328-9","article-title":"Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models","volume":"9","author":"Souchet","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2021.101871_bib163","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.clnu.2015.04.012","article-title":"Green tea EGCG plus fish oil omega-3 dietary supplements rescue mitochondrial dysfunctions and are safe in a Down's syndrome child","volume":"34","author":"Vacca","year":"2015","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.redox.2021.101871_bib164","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3746\/pnf.2016.21.4.317","article-title":"Effects of eicosapentaenoic acid and docosahexaenoic acid on mitochondrial DNA replication and PGC-1\u03b1 gene expression in C2C12 muscle cells","volume":"21","author":"Lee","year":"2016","journal-title":"Prev. Nutr. Food Sci."},{"key":"10.1016\/j.redox.2021.101871_bib165","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.nutres.2015.02.007","article-title":"Fish oil improves gene targets of Down syndrome in C57BL and BALB\/c mice","volume":"35","author":"Zmijewski","year":"2015","journal-title":"Nutr. Res."},{"key":"10.1016\/j.redox.2021.101871_bib166","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12986-015-0006-5","article-title":"AMP-activated protein kinase is required for the anti-adipogenic effects of alpha-linolenic acid","volume":"12","author":"Zhou","year":"2015","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.redox.2021.101871_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010136","article-title":"Alpha-linolenic acid-enriched butter promotes fatty acid remodeling and thermogenic activation in the Brown adipose tissue","volume":"12","author":"You","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.redox.2021.101871_bib168","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8908901","article-title":"The effects of alpha-linolenic acid on the secretory activity of astrocytes and \u03b2 amyloid-associated neurodegeneration in differentiated SH-SY5Y cells: alpha-linolenic acid protects the SH-SY5Y cells against \u03b2 amyloid toxicity","volume":"2020","author":"Litwiniuk","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2021.101871_bib169","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/jn\/nxaa074","article-title":"Prenatal administration of oleic acid or linolenic acid reduces neuromorphological and cognitive alterations in Ts65dn down syndrome mice","volume":"150","author":"Garc\u00eda-Cerro","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.redox.2021.101871_bib170","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijdevneu.2011.09.006","article-title":"Maternal \u03b1-linolenic acid availability during gestation and lactation alters the postnatal hippocampal development in the mouse offspring","volume":"29","author":"Niculescu","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib171","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mus.24692","article-title":"Metformin increases peroxisome proliferator-activated receptor \u03b3 Co-activator-1\u03b1 and utrophin a expression in dystrophic skeletal muscle","volume":"52","author":"Ljubicic","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.redox.2021.101871_bib172","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bbadis.2018.01.018","article-title":"Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: relevance in age-associated vascular dysfunction","volume":"1864","author":"Karnewar","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.redox.2021.101871_bib173","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/bab.1584","article-title":"Metformin promotes neuronal differentiation and neurite outgrowth through AMPK activation in human bone marrow-mesenchymal stem cells","volume":"64","author":"Ahn","year":"2017","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.redox.2021.101871_bib174","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518766524","article-title":"\u03b2-Guanidinopropionic acid stimulates brain mitochondria biogenesis and alters cognitive behavior in nondiseased mid-age mice","volume":"12","author":"Gureev","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib175","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1523\/JNEUROSCI.0426-16.2016","article-title":"Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced experimental Parkinson\u2019s-like disease","volume":"36","author":"Ahuja","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib176","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/brain\/awt340","article-title":"Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model","volume":"137","author":"Guidi","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.redox.2021.101871_bib177","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ajhg.2020.10.001","article-title":"Apigenin as a candidate prenatal treatment for trisomy 21: effects in human amniocytes and the Ts1Cje mouse model","volume":"107","author":"Guedj","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib178","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/jn\/nxaa207","article-title":"Prenatal, but not postnatal, curcumin administration rescues neuromorphological and cognitive alterations in Ts65Dn down syndrome mice","volume":"150","author":"Rueda","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.redox.2021.101871_bib179","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s11064-014-1315-1","article-title":"Curcumin prevents cerebral ischemia reperfusion injury via increase of mitochondrial biogenesis","volume":"39","author":"Liu","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.redox.2021.101871_bib180","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ardp.201400266","article-title":"Mitochondria as a target in the therapeutic properties of curcumin","volume":"347","author":"Trujillo","year":"2014","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.redox.2021.101871_bib181","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.biotechadv.2016.04.004","article-title":"Curcumin, mitochondrial biogenesis, and mitophagy: exploring recent data and indicating future needs","volume":"34","author":"de Oliveira","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.redox.2021.101871_bib182","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700218","article-title":"Apigenin ameliorates the obesity\u2010induced skeletal muscle atrophy by attenuating mitochondrial dysfunction in the muscle of obese mice","volume":"61","author":"Choi","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.redox.2021.101871_bib183","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2018.06.013","article-title":"Long term effects of neonatal exposure to fluoxetine on energy balance: a systematic review of experimental studies","volume":"833","author":"Barros","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2021.101871_bib184","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1002\/jcb.26758","article-title":"Neonatal treatment with fluoxetine improves mitochondrial respiration and reduces oxidative stress in liver of adult rats","volume":"119","author":"Sim\u00f5es\u2010Alves","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.redox.2021.101871_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173200","article-title":"Fluoxetine administration in juvenile overfed rats improves hypothalamic mitochondrial respiration and REDOX status and induces mitochondrial biogenesis transcriptional expression","volume":"881","author":"Braz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2021.101871_bib186","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12035-011-8181-5","article-title":"Modulation of nrf2\/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders","volume":"44","author":"Scapagnini","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2021.101871_bib187","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2015.04.036","article-title":"Nrf2-signaling and BDNF: a new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety\/depression","volume":"597","author":"Mendez-David","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2021.101871_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10443-6","article-title":"The Chinese herbal formula Free and Easy Wanderer ameliorates oxidative stress through KEAP1-NRF2\/HO-1 pathway","volume":"7","author":"Hong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2021.101871_bib189","doi-asserted-by":"crossref","first-page":"14108","DOI":"10.1074\/jbc.M116.770925","article-title":"Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses","volume":"292","author":"Perez-Leal","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101871_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9372182","article-title":"Activators and inhibitors of NRF2: a review of their potential for clinical development","author":"Robledinos-Ant\u00f3n","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2021.101871_bib191","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/cells9112346","article-title":"Prevention by dietary polyphenols (resveratrol, quercetin, apigenin) against 7-ketocholesterol-induced oxiapoptophagy in neuronal N2a cells: potential interest for the treatment of neurodegenerative and age-related diseases","volume":"9","author":"Yammine","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.redox.2021.101871_bib192","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1124\/mol.106.033845","article-title":"The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells","volume":"71","author":"Ghosh","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.redox.2021.101871_bib193","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/bph.12413","article-title":"Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models","volume":"171","author":"Komen","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2021.101871_bib194","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fgene.2019.00606","article-title":"Pioglitazone improves mitochondrial organization and bioenergetics in down syndrome cells","volume":"10","author":"Mollo","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2009.03.014","article-title":"PPARgamma stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells","volume":"454","author":"Miglio","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2021.101871_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018433","article-title":"Mild mitochondrial uncoupling and calorie restriction increase fasting eNOS, akt and mitochondrial biogenesis","volume":"6","author":"Cerqueira","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.redox.2021.101871_bib197","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1152\/japplphysiol.01177.2013","article-title":"Mitochondrial uncoupling reduces exercise capacity despite several skeletal muscle metabolic adaptations","volume":"116","author":"Schlagowski","year":"2014","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.redox.2021.101871_bib198","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1096\/fj.99-0853","article-title":"Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease","volume":"14","author":"Farber","year":"2000","journal-title":"Faseb. J."},{"key":"10.1016\/j.redox.2021.101871_bib199","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1096\/fj.05-3812com","article-title":"Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound","volume":"19","author":"Wasilewska-Sampaio","year":"2005","journal-title":"Faseb. J."},{"key":"10.1016\/j.redox.2021.101871_bib200","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.scr.2013.09.016","article-title":"2,4-Dinitrophenol induces neural differentiation of murine embryonic stem cells","volume":"11","author":"Freitas-Correa","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.redox.2021.101871_bib201","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(00)02205-8","article-title":"Phospholipid composition and levels are altered in Down syndrome brain","volume":"867","author":"Murphy","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2021.101871_bib202","first-page":"129","article-title":"Small-molecule aggregation inhibitors reduce excess amyloid in a trisomy 16 mouse cortical cell line","volume":"41","author":"Paula Lima","year":"2008","journal-title":"Biol. Res."},{"key":"10.1016\/j.redox.2021.101871_bib203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11064-018-2588-6","article-title":"A ketogenic diet improves mitochondrial biogenesis and bioenergetics via the PGC1\u03b1-SIRT3-UCP2 Axis","volume":"44","author":"Hasan-Olive","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.redox.2021.101871_bib204","first-page":"42","article-title":"Effect of ketogenic diets in gestation on some characteristics of carbohydrate metabolism in fetal pig brain and liver","volume":"45","author":"Rosebrough","year":"1981","journal-title":"Growth"},{"key":"10.1016\/j.redox.2021.101871_bib205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgmr.2016.03.012","article-title":"Beneficial effect of feeding a ketogenic diet to mothers on brain development in their progeny with a murine model of pyruvate dehydrogenase complex deficiency","volume":"7","author":"Pliss","year":"2016","journal-title":"Mol. Genet. Metab. Reports."},{"key":"10.1016\/j.redox.2021.101871_bib206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.29245\/2578-2940\/2018\/2.1121","article-title":"The ketogenic diet as a potential therapy in down syndrome","volume":"2","author":"Kaneko","year":"2018","journal-title":"J. Pediatr. Pediatr. Med."},{"key":"10.1016\/j.redox.2021.101871_bib207","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3233\/JAD-140384","article-title":"OXPHOS, pyrimidine nucleotides, and Alzheimer's disease: a pharmacogenomics approach","volume":"42","author":"Pesini","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.redox.2021.101871_bib208","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10863-018-9760-1","article-title":"O-GlcNAc cycling in the developing, adult and geriatric brain","volume":"50","author":"Lagerl\u00f6f","year":"2018","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.redox.2021.101871_bib209","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn2593","article-title":"Plasma membrane expansion: a neuron's Herculean task","volume":"10","author":"Pfenninger","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.redox.2021.101871_bib210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/hmg\/ddm058","article-title":"Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis","volume":"16","author":"L\u00f3pez-Mart\u00edn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101871_bib211","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/dneu.22716","article-title":"Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease","volume":"79","author":"Gross","year":"2019","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.redox.2021.101871_bib212","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1081\/NCN-200027545","article-title":"Severe impairment of nucleotide synthesis through inhibition of mitochondrial respiration","volume":"23","author":"Gattermann","year":"2004","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.redox.2021.101871_bib213","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2013.04.016","article-title":"Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome","volume":"58","author":"Velazquez","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2021.101871_bib214","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1096\/fj.15-282426","article-title":"Maternal dietary intake of choline in mice regulates development of the cerebral cortex in the offspring","volume":"30","author":"Wang","year":"2016","journal-title":"Faseb. J."},{"key":"10.1016\/j.redox.2021.101871_bib215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2017.09.038","article-title":"Synapse formation in the brain can be enhanced by co-administering three specific nutrients","volume":"817","author":"Wurtman","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2021.101871_bib216","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/1871527318666191114092924","article-title":"Pharmacotherapy of down's syndrome: when and which?","volume":"18","author":"Tayebati","year":"2020","journal-title":"CNS Neurol. Disord. - Drug Targets"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T19:39:30Z","timestamp":1715024370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231721000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":216,"alternative-id":["S2213231721000197"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2021.101871","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/NUVVCL","asserted-by":"object"}]},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down syndrome is an oxidative phosphorylation disorder","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2021.101871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101871"}}